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> 0.05, ANOVA). Postmortem evaluation
revealed that 2-3 hepatic veins were
transected by injury type 1, 1-2 portal vein
branches plus 1 hepatic vein were transected
by injury type 3 (LLL transection).
Conclusions: The hemorrhage severity of the
central stellate injury was inadequate, while
hemorrhage from excision of a proximal
branch of the portal vein appeared to be too
severe (i.e., the subjects died too quickly).

Near-transection of the hepatic LLL at its base
appeared to yield hemorrhage of appropriate
severity, as indicated by the 40% 1-hour
mortality and intermediate values for MAP,
blood loss, and other variables. Our plan is to
use this latter injury model in the development
of therapies for noncompressible truncal
hemorrhage. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.047
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Exogenous Testosterone Supplementation as Cause of Ischemic Stroke, Mediated through
Secondary Erythrocytosis
Fuad-al Ali, Amy Hellman, Pierre Fayad

Mentor: Pierre Fayad
Program: Neurology
Background: The use of exogenous
testosterone has become more prevalent in
recent years but the effects of such use in
regards to potential cerebrovascular disease
have yet to come to a conclusion. In this case
report, we discuss a patient who suffered
an ischemic stroke due to testosterone
supplementation.
Case presentation: A middle-aged
patient with history of hypertension and
hyperlipidemia that presented with falls,

difficulty performing simple tasks and slurred
speech. Patient had been taking testosterone
injections every 6 months for the prior 2 years
for loss of energy and reported low levels.
Lab work revealed a hemoglobin of 20 g/dL
and a hematocrit of 51.5%. MRI of the brain
showed a left striatocapsular ischemic infarct.
He was given the diagnosis of ischemic stroke
due to polycythemia and thrombus formation
secondary to testosterone supplementation.

association with ischemic stroke and there
may be an optimal level that is safe.
Conclusion: The risk of ischemic stroke may
be related to testosterone and DHT levels but
no clear guidelines exist on optimal levels
in supplementation. Thus, clinicians should
be aware of the potential risk and monitor
androgen and hematocrit levels. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.048

Discussion: Testosterone and
dihydrotestosterone (DHT) has both
protective and adverse effects. Both low and
high levels of testosterone and DHT have an
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Program: Neurology
Objective: To assess the effectiveness of
treatment for status epilepticus (SE) at UNMC
and determine patient health outcomes related
to the delayed control of seizures
Design/Methods: Retrospective chart
review was performed on 1565 adult
patients who underwent continuous video
electroencephalography (cvEEG) for
suspected seizures between January 1, 2012
and February 28, 2018.
Results: 49 patients had and were treated for
64 incidences of convulsive or nonconvulsive

SE recorded on cvEEG or clinical seizures
longer than 5 min which were documented by
a neurologist. Among 64 cases, 55 incidences
required the second AED treatment, and
40 out of 55 cases were treated with the
third AED subsequently. The mean seizure
detection-to-needle time for the first,
second, and third antiepileptic drugs were
167, 239, and 297 minutes, respectively.
Benzodiazepines were administered as the
first AED in only 46 % of all treated cases.
The duration of the hospital stays in patients
treated with the first AED within 60 min after
seizure detection was shorter compared to
those whose treatment was delayed (23.0 vs.

33.6 days, p=0.41). The mortality rate in the
former group was lower than that in the group
which did not receive AEDs within 60 min
(28.6 vs. 53.6%, p=0.02).
Conclusion: The current treatment approaches
for SE at UNMC are inefficient with
significant delay in delivery of medications
after seizure detection; they may contribute
to the prolonged hospital stay and increased
mortality. In order to improve patient care, the
existing protocol for the treatment of SE at
UNMC must be revised. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.049
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Background: VNS Therapy has demonstrated
overall cost savings in patients with drug-
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resistant epilepsy. The overall goal of this
project is to evaluate the clinical and cost
effectiveness of the Aspire SR 106 VNS
(Vagus Nerve Stimulator) system, using
retrospective patient data. We anticipate
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the extra dimension of closed-loop
autostimulation in the Aspire 106 model will
demonstrate more efficient utilization of
health care resources.
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Methods: Data were collected using
EPIC® starting 12 months prior to VNS
replacement to Aspire ® device to 12 months
after implantation date in 3-month blocks.
Seizure frequency before and after the VNS
implantation as well as medication changes
were identified from review of clinic notes.
Cost was estimated based on the number
of visits for ER, clinic, hospital, and ICU
using hospital average cost data. As cost
distributions are skewed to the right, we also
calculated log total costs for the trend analysis
using segmented model. For data analysis
segmented Poisson regression was used to
establish a trend in usage per quarter.

Results: The trend in Clinic usage was
statistically flat (p > 0.05) in the preplacement period while the trend in the post
placement was downward with an estimate
that for every quarter the natural log of the
average number of clinic visits decreases by
0.29. By one-year post placement, the average
number of clinic visits had achieved the same
level as the pre-placement period. The trends
in ER and hospital usage were flat in both the
pre and post placement periods. The median
number of CPS in the year after placement of
the Aspire 106 VNS was statistically smaller
by 1 (p = 0.0161) CPS than the median
number of CPS in the year prior to placement.

Conclusion: Analysis of the above data
yielded two main findings: there were no
demonstrable cost savings within a 12-month
period following VNS implantation, but the
median burden of Complex Partial Seizures
(CPS) within our cohort revealed a 50%
decline, which was statistically significant.
However, overall costs post-implantation
showed a consistent downward trajectory,
with approximation to pre-implantation costs
within the 12-month timeframe.
https://doi.org/10.32873/unmc.dc.gmerj.1.1.050
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Objective: To describe the clinical features,
MRI findings, and neuroanatomy of a patient
with a punctate brainstem stroke.
Method: Characterize the eye movement
deficits in this patient and correlate the MRI
diffusion restriction findings.

Results: This patient presented with vertical
gaze palsy and impaired adduction of the
left eye. Impaired smooth pursuits up and
down clinically localized to damage in the
interstitial nucleus of Cajal. Impaired saccades
up and down localized to the rostral interstitial
nuclei of the medial longitudinal fasciculus.
MRI showed diffusion restriction in the left

thalamus-midbrain junction just posterior to
the red nucleus.
Conclusion: This case illustrates how a
punctate single unilateral lesion can present
with vertical supranuclear gaze palsy and
horizontal eye movement abnormalities. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.051
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Background: We were consulted a young
adult patient who presented following a motor
vehicle accident. The patient presented with
diffuse axonal injury, hemorrhage of left basal
ganglia increased intra-cranial pressure and
other injuries. The patient was intubated, an
intraventricular shunt had been removed and
a 7-day course of Keppra prophylaxis had
been finished. The patient was stable until the
morning we were consulted.
Methods: On exam the patient had episodes
of extensor posturing, diffuse dystonia and
high frequency, low amplitude tremors, with
autonomic instability limited to these spells.

The patient was found to have 3+ reflexes
throughout. Brain stem reflexes were intact.
Stimuli caused extensor posturing, rigidity
and autonomic instability. Continuous VEEG
showed epileptiform activity that did not
correlate with spells on video. Lab was
non-specific expect for a reelevated CK. We
loaded Keppra and prn diazepam. This failed
to control the symptoms.
Results: We arrived at a diagnosis of
paroxysmal autonomic instability and
dystonia (PAID) syndrome. Treatment with
clonazepam, Gabapentin, baclofen and
propranolol stabilized the autonomic system
and resolved the dystonia. The CK began
to drop and the patient began to respond to
commands.

Conclusions: PAID most commonly
affects young persons following severe
TBI. Potentially caused by disinhibition
of sympathoexcitatory regions leading to
cortically provoked catecholamine surges
causing autonomic instability. Dystonia
is secondary to disruption of the pontine
and vestibular nuclei. PAID should on the
differential diagnosis of TBI patients who
are not responding to typical treatments.
We had success treating with Clonazepam,
gabapentin, baclofen and propranolol. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.052
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Introduction: The differentiation between
demyelinating lesions and primary brain
neoplasms is difficult based on radiography
alone, resulting in misdiagnoses and delay
in treatment. Here we present two cases
with MRI abnormalities suggestive of either

demyelination or neoplasm. Case 1 was
treated with steroids for a demyelinating
process, but was found on biopsy to have an
anaplastic astrocytoma that was unresectable
by the time of diagnosis. Case 2 was thought
to be glioma but was later determined to be
tumefactive demyelination. In both cases,
there were delays due to the limitations of MR
imaging. 
Dec. 2019 | Vol. 1 | Issue 1

Methods: The cases of the two patients
were reviewed via EMR. A literature review
investigated the most sensitive and specific
non-invasive diagnostic modalities for
diagnosing demyelinating lesions or primary
brain neoplasms.
 esults: Review of recent literature shows
R
that conventional MR sequences have
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